Tk Nucera stock steadies after guidance cut as hydrogen orders double
Published on 08/20/2026 at 21:54 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Tk Nucera AG & Co. KGaA (ISIN DE000NCA0001) stock is trading close to EUR7.83 on the German market as of August 19, 2026, reflecting a cautious investor reaction to the company’s latest guidance update for fiscal 2025/2026.
Per a recent overview of the share, the last indicated price stands at EUR7.830, with the quote taken from Tradegate trading on August 20, 2026, showing the stock marginally higher over the past five days and modestly positive since the start of 2026. The Marketscreener data on Tk Nucera price and performance highlights a five-day gain of 0.13 percent and a year-to-date gain of 0.84 percent as of August 20, 2026.
Guidance cut offsets strong order growth
The parent group’s latest fiscal 2025/2026 communication shows a mixed picture: the steel and industrial conglomerate has raised the floor of its full-year adjusted EBIT guidance to EUR600 million to EUR900 million, up from a previous range of EUR500 million to EUR900 million, following stronger-than-expected third-quarter results reported for the period ended June 30, 2026. An in-depth article on Thyssenkrupp Q3 2025/2026 and its green strategy notes that the improved group guidance underscores growing confidence in the core steel and materials businesses.
Within that context, Tk Nucera’s own outlook has moved in the opposite direction. For the current fiscal year 2025/2026, the hydrogen-focused subsidiary has cut its revenue guidance to a range of EUR450 million to EUR500 million, compared with a previously higher expectation, while forecasting an EBIT loss between EUR75 million and EUR105 million for the same period. The same analysis detailing Tk Nucera guidance and SOEC-related charges attributes the deeper loss outlook to one-off costs tied to a strategic decision on solid oxide electrolyzer technology, suggesting that the guidance cut is driven more by extraordinary items than by a collapse in demand.
Despite the near-term earnings drag, order momentum is robust. In its Q3 statement for fiscal 2025/2026, Tk Nucera reported that order intake in the first nine months of the year has doubled compared with the same period of the prior fiscal year, signaling that customers are committing to large-scale hydrogen projects even as the company absorbs the impact of restructuring and technology pivots. Marketscreener coverage of Tk Nucera’s Q3 2025/2026 statement highlights the doubled order intake as a key positive, framing the business as one where the backlog is building while profitability lags.
Latest Q3 2025/2026 figures and investor context
The Q3 2025/2026 reporting period ended June 30, 2026, and represents Tk Nucera’s most recent set of financials available as of August 20, 2026. According to the same Q3 communication summarized in recent coverage, the company’s updated revenue range of EUR450 million to EUR500 million for fiscal 2025/2026 implies a more restrained trajectory than earlier ambitions, yet still indicates solid top-line expansion versus the previous fiscal year, when the hydrogen business was materially smaller and operating at an earlier stage of commercialization.
On the earnings side, the projected EBIT loss of EUR75 million to EUR105 million for fiscal 2025/2026 compares with a narrower loss in the prior year, underlining how one-off costs connected to strategic technology decisions and scaling investments are weighing on near-term margins. The fact that these charges are explicitly tied to a repositioning of the SOEC portfolio suggests that investors need to separate structural profitability trends from temporary restructuring effects when assessing the guidance revision.
From a market perspective, the EUR7.830 price level as of August 20, 2026, places Tk Nucera shares well below a fair value estimate cited in a global screening overview, which lists the stock at EUR7.835 versus an estimated value of EUR15.66, implying a discount of roughly 50 percent. A valuation overview mentioning Tk Nucera’s discount positions the hydrogen specialist among stocks potentially priced below estimated intrinsic value, although such model-based fair values depend on assumptions regarding future hydrogen adoption, order conversion, and margin recovery.
The market-data snapshot for Tradegate as of August 20, 2026, also shows that Tk Nucera’s share price has gained 0.13 percent over the last five sessions and 0.84 percent since the start of 2026, a relatively modest performance that contrasts with the more pronounced appreciation seen in some broader industrial and clean-tech indices. While the stock has avoided sharp declines despite the guidance cut, the lack of a strong upside reaction indicates that investors are still cautious about the balance between growing order books and negative earnings.
Hydrogen electrolyzers as the core product
Tk Nucera’s core business is the design and manufacture of large-scale electrolysis systems used to produce green hydrogen from renewable electricity and water. The company develops alkaline water electrolyzers and is actively working on solid oxide electrolyzer technology, aiming to deliver high-efficiency solutions for industrial decarbonization projects in steel, chemicals, and refineries. These products are typically deployed in multi-hundred-megawatt projects where hydrogen replaces fossil fuels in high-temperature processes.
The Q3 2025/2026 update underscores how this product pipeline translates into commercial traction: the doubling of order intake in the first nine months of fiscal 2025/2026 suggests that customers in Europe and other regions are moving from pilot projects to larger-scale investments. Each such project can entail substantial equipment volumes, long lead times, and service contracts, which over time should support recurring revenue streams and higher margins once the initial build-out phase is complete.
As the company absorbs the SOEC-related one-off costs that have widened the expected EBIT loss, management’s strategic focus is likely to remain on sharpening the product portfolio, improving manufacturing efficiency, and aligning capacity with the most promising application segments. For investors, the key question is whether the current fiscal year’s loss can be viewed as a transition cost toward a more profitable product mix, or whether it signals ongoing structural challenges in monetizing hydrogen electrolyzer technology at scale.
Shares hover below fair value models
From a trading-venue standpoint, Tk Nucera shares are listed on the Frankfurt Stock Exchange and traded on platforms such as Tradegate, with the latest quoted level of EUR7.830 as of August 20, 2026, reflecting a modest gain over the prior five days and a small year-to-date advance. This price stands roughly halfway between the zero level and the EUR15.66 fair value estimate referenced by valuation screens, underscoring the degree to which current market pricing embeds skepticism regarding the company’s ability to convert its doubled order intake into positive EBIT in the medium term.
In that context, the quantified comparison between the EUR7.830 market price and the EUR15.66 model-based fair value estimate points to a discount in the region of 50 percent, suggesting that a substantial part of the potential future cash flow implied by the hydrogen project pipeline is not yet reflected in the share price.
As of the last completed trading session on August 19, 2026, Tk Nucera stock closed close to EUR7.83 on German platforms, a level that investors will watch closely over the coming weeks to gauge whether the combination of strong order growth and a heavier EBIT loss outlook is sufficient to attract new buyers or whether further clarity on margins and project execution will be needed before the share can re-rate.
Go deeper
Read more on Tk Nucera stock fundamentals and hydrogen strategy via recent Q3 2025/2026 reporting and valuation commentary from market-data platforms and analytical overviews that track the company’s guidance range, order intake, and model-based fair value estimates.
Investor Relations
Further information on Tk Nucera’s business, governance, and detailed financial reports is available through the company’s official investor relations presence, which collects quarterly statements, fiscal-year results, and strategy updates related to its electrolysis portfolio and hydrogen market positioning.
Fact box
Company: Tk Nucera AG & Co. KGaA
ISIN: DE000NCA0001
Ticker: NCH2
Exchange: Frankfurt Stock Exchange (Tradegate quotation)
Price (as of August 19, 2026, 4:00 p.m. local market time): EUR7.83
Market cap: figure not specified in the available sources
Sector / Industry: Industrials / Hydrogen technology and equipment
Index membership: figure not specified in the available sources
